Introduction
============

Attention deficit hyperactivity disorder (ADHD) is a rather common (5%--10%) ([@b1]) psychiatric disorder in schoolchildren between the age of six to ten years. The details of the etiology and pathophysiology of this disorder have still to be worked out, but available data implicate a dysregulation of the catecholaminergic system and this malfunction might be effected by polymorphisms of several genes involved in this system ([@b8]; [@b7]). Twin studies have demonstrated a high degree of heredity (0.6--0.9) in this disorder ([@b15]). Molecular genetic studies of ADHD have focused on genes in catecholaminergic pathways because animal models, theoretical considerations, and the effectiveness of stimulant treatment implicate catecholaminergic dysfunction in the pathophysiology of the disorder ([@b7]).

Candidate genes for association and linkage studies are those involved in the dopamine pathway like the dopamine receptor D~4~ (*DRD4*) and the dopamine transporter 1 (*DAT1*) genes. Numerous molecular genetic studies have been conducted with ambiguous findings. These studies were lately used for two meta-analyses to increase the statistical power of the findings ([@b8]; [@b11]; [@b12]; [@b15]).

Most of these studies have been almost exclusively conducted in North America and none were conducted in central Europe during the last eight years. We decided to recruit patients with ADHD in southern Germany and the western part of Austria. To increase the comparability of the diagnosis we used a computer-based diagnostic scheme for evaluation of all diagnosis. This computer program was developed by Sarah Curran and colleagues at the Institute of Psychiatry, London, United Kingdom under the name "Hypescheme" and can be downloaded from the following webpage <http://iop.kcl.av.uk/IoP/Departments/SGDPsy/Hypescheme.shtml> ([@b3]) and is closely related to the Conner's rating system ([@b2]).

The hyperactive patients were recruited in three different locations. To circumvent problems of stratification due to differences in ethnic background, we choose to perform a family based study ([@b6]; [@b16]). Children with diagnosed ADHD were recruited together with their parents.

In the present paper the diagnosis of attention deficit hyperactivity disorder was evaluated with the "Hypescheme" program. The patients with ADHD and their parents were analyzed for the repeat polymorphism in the *DRD4* (48bp-repeat) and the *DAT1* (3'-40bp repeat) genes. Statistical analysis was performed by the haplotype relative risk (HRR) and the transmission disequilibrium test (TDT) methods ([@b6]; [@b16]). To also include pairs (1 affected child and one parent), the possible genotype of the missing parent was reconstructed and added to the analysis after weighting the genotypes according to occurrences in the normal population ([@b4]; [@b9]).

Methods
=======

Patient recruitment and diagnosis evaluation
--------------------------------------------

Patients and their parents were recruited at institutions specialized in diagnosis and treatment of children with ADHD. These institutions were located in Innsbruck and Salzburg, Austria and Böblingen, Germany. In order to standardize the diagnosis, all patients were evaluated with the "Hypescheme" program after its release in 2000. Also children with other or no psychiatric disorders were diagnosed with the "Hypescheme" program to evaluate this program with respect to false -- positive results. All parents gave informed consent for this study.

DNA isolation
-------------

DNA was isolated from 5--10 ml of EDTA-blood. First, erythrocyte-lysis puffer (155 mM NH~4~CL, 10 mM KHCO~3~) was added to the blood (10 to1 v/v) and left for 30 min on ice. After centrifugation at 3000 g for 15 min the pellet was washed with erythrocyte-lysis puffer and the centrifugation was repeated. Only the tightly precipitated pellet was used. The pellet was solubilized with 10x Taqpolymerase buffer (0.5 M KCl, 0.1M Tris-HCl pH 9.0 and 15 mM MgCl~2~), 2% Triton X-100 and 0.2 mg/ml Pronase A (Roche, Switzerland). This solution was about 1/10 of the whole blood volume and incubated for 3 h at 55 °C. After an inactivation at 95 °C for 15 min, the solution was vortexed, placed immediately on ice, and Pefabloc (Roche, Switzerland) was added at a final concentration of 0.1% and the solution was kept at 4 °C and used for polymerase chain reaction (PCR).

PCR of *DRD4* and the *DAT1* polymorphism
-----------------------------------------

PCR for the *DRD4* polymorphism was done according to [@b13] with some modification. Dimethylsulfoxide was omitted and we used "Hot start"-Taq polymerase with Q-solution from Quiagen (Quiagen, Valencia, USA). The 200 μmol/L of deazaguanosine was replaced by 100 μmol/L deazaguanosine and 100 μmol/L guanosine. Electrophoresis of the PCR-fragments was run on a 4% Metaphor^®^ gel (BMA Bioproducts, Rockland USA). PCR for the *DAT1* polymorphism was performed according to [@b4].

Statistical analysis
--------------------

For the statistical evaluation of our data we used two different approaches. One was the HRR estimation ([@b14]) and the other was the TDT ([@b6]).

For HRR, we counted all alleles that were passed to the patient in each trio and assigned them to the "cases" group whereas the untransmitted alleles were assigned to the "control" group. All alleles were counted also for homozygous parents. These numbers can be analyzed by 2 × 2 contingency tables for odds ratio and significant differences.

For the TDT, only the alleles of the informative trios were counted for transmission (T) or no-transmission (NT). Noninformative cases were omitted. To test if one allele is significantly more transmitted, the following formula is used: (T-NT)^2^/T+NT = χ^2^ (McNemar-test). To calculate the odds ratio in a 2 × 2 contingency table the T and NT values were placed in the first row and the value for (T+NT)/2 twice in the second row.

Results
=======

Evaluation of the "Hypescheme" program
--------------------------------------

We have recruited 43 male and 6 female Caucasian patients (6--13 years, mean 8.4, SD 2.2) in three centres (Innsbruck, Salzburg, and Böblingen) encompassing 36 trios (parents and child) and 13 pairs (one parent and child). All children had ADHD according to the DSM-IV criteria. 10 suffered from additional conduct disorders and 5 from learning disorders. Other psychiatric/psychological disorders such as depression or anxiety disorders were defined as exclusion criteria. Diagnosis was confirmed by the "Hypescheme" program (16 attention deficits, 4 hyperactive, and 29 combined). The sensitivity and specificity of the "Hypescheme" program are both 1.0 according to DSM-IV criteria. The diagnostic algorithm of the program identifies hyperactive children with a specifity of 1.0 (sensitivity 0.33) according to ICD-10 criteria ([@b12]).

Dopamine receptor D~4~ polymorphism and ADHD
--------------------------------------------

The analysis of our sample of parents and children with ADHD demonstrated the existence of six different alleles in the DRD4 gene. We observed 2, 3, 4, 6, 7, and 8 alleles according to the nomenclature of [@b17]. None of these was significantly associated with ADHD in the 36 trios, neither by the haplotype relative risk nor by the transmission disequilibrium test ([Table 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}). When the "risk" allele (number 7 allele) was compared with the other alleles, a nonsignificant (p = 0.88) odds ratio of 0.93 (95% CI 0.35--2.47) by the HRR method and a χ^2^ = 0.04 (odds ratio = 0.92; 95% CI 0.24--3.47) by the TDT method was obtained. If the 13 pairs were added to the calculation, similar results were observed ([Table 1a](#tbl1a){ref-type="table"} and [2a](#tbl2a){ref-type="table"}).

###### 

Allele count for the haplotype relative risk calculation of the DRD4 polymorphism of the 36 Trios

               Alleles                      
  ------------ --------- --- ---- ---- ---- ----
               2         3   4    6    7    8
  Cases        10        7   43   1    11   --
  "controls"   5         3   50   --   12   2

**Statistics:** Allele 7 against all others: OD 0.93 (95% CI 0.35--2.47) p = 0.88.

###### 

Allele count for the transmission disequilibrium test of the DRD4 polymorphism of the 36 Trios

                    Not transmitted                   
  ------------- --- ----------------- --- --- --- --- ---
                    2                 3   4   6   7   8
  transmitted   2                         7       2   
                3                         7       1   
                4   6                 1           8   2
                6                                 1   
                7   2                     9           
                8                                     

**Statistics:** Allele 7 against all others: χ^2^ = 0.04 OD = 0.92 (95% CI 0.24--3.47).

###### 

Allele count for the haplotype relative risk calculation of the DRD4 polymorphism of the 36 Trios and 13 Duos

               Alleles   
  ------------ --------- --------
               7         others
  Cases        19        79
  "controls"   19,4      79,6

**Statistics:** OD = 1.01 (95% CI 0.47--2.18) p = 1.0.

###### 

Allele count for the transmission disequilibrium test of the DRD4 polymorphism of the 36 Trios and the 13 Duos

                         Not transmitted   
  ------------- -------- ----------------- --------
                         7                 others
  transmitted   7                          18,15
                others   17,125            

**Statistics:** χ^2^ = 0.04 OD = 0.94 (95% CI 0.33--2.70).

Dopamine transporter 1 polymorphism and ADHD
--------------------------------------------

The examination of our sample of parents and children with ADHD exhibited three different alleles of the *DAT1* gene which were designated 5, 6, and 7 according to the nomenclature of [@b4]. We did not observe any significant association with ADHD in the 36 trios, neither by the haplotype relative risk nor by the transmission disequilibrium test ([Table 3](#tbl3){ref-type="table"} and [4](#tbl4){ref-type="table"}). Comparison of the "risk" allele (number 6 allele) with the other alleles gave a nonsignificant result. An odds ratio of 1.0 (95% CI 0.42--2.35) (p = 0.0) was obtained by the HRR method and a χ^2^ = 0.0 (odds ratio = 1.0; 95% CI 0.31--3.25) was obtained by the TDT method. If the 13 pairs were added to the calculation, similar results were observed ([Table 3a](#tbl3a){ref-type="table"} and [4a](#tbl4a){ref-type="table"}).

###### 

Allele count for the haplotype relative risk calculation of the DAT1 polymorphism of the 36 Trios

               Alleles        
  ------------ --------- ---- ---
               5         6    7
  Cases        16        56   
  "controls"   14        56   2

**Statistics:** Allele 6 against all others: χ^2^ = 0.0 OD = 1.0 (95% CI 0.42--2.35).

###### 

Allele count for the transmission disequilibrium test of the DAT1 polymorphism of the 36 Trios

                    Non transmitted        
  ------------- --- ----------------- ---- ---
                    5                 6    7
  transmitted   5                     14   1
                6   13                     1
                7                          

**Statistics:** Allele 6 against all others: χ^2^ = 0.0 OD = 1.0 (95% CI 0.31--3.25).

###### 

Allele count for the haplotype relative risk calculation of the DAT1 polymorphism of the 36 Trios and 13 Duos

               Alleles          
  ------------ --------- ------ ---
               5         6      7
  Cases        24        73     
  "controls"   20,6      75,4   2

**Statistics:** Allele 6 against all others: χ^2^ = 0.04 OD = 0.91 (95% CI 0.46--1.89).

###### 

Allele count for the transmission disequilibrium test of the DAT1 polymorphism of the 36 Trios and the 13 Duos

                    Non transmitted           
  ------------- --- ----------------- ------- ---
                    5                 6       7
  transmitted   5                     19,95   1
                6   17,5                      1
                7                             

**Statistics:** Allele 6 against all others: χ^2^ = 0.17 OD = 0.88 (95% CI 0.33--2.44).

Discussion
==========

We present a study that is the first to use the computer-based program, "Hypescheme", which is based on DSM-IV for diagnosis of ADHD. It is also the first that is conducted with a sample from central Europe.

Using the "Hypescheme" computer program to diagnose ADHD introduces a new diagnostic tool that shows high sensitivity and specifity. Since it can be used by other investigators in the same way, it might be a good tool to standardize the diagnosis of ADHD.

This study does not support the previous findings of an association between the *DRD4* 7-allele and the *DAT1* 6-allele and ADHD.

Two meta-analyses ([@b8]; [@b12]) have only come up with a significant association when several studies were combined, although the odds ratios were not very different from 1.00. Meta-analyses are always prone to publication bias. Although one publication ([@b8]) claims to have checked for this bias with the method published by [@b5] the later method has not been mathematically correctly applied.

Just recently a new publication ([@b10]) has been issued from a group that has formerly observed a positive association with the *DRD4* polymorphism and was included in the meta-analyses ([@b8]; [@b12]). Now in a larger sample they no longer detect this association and also found no association with the *DAT1* polymorphism.

It is very important to publish all results from association studies regardless as to whether they reveal positive, negative, or no association at all.

Limitations
-----------

Although we have to admit that our study is quite small (36 trios and 13 pairs), it fits into the general picture that only a very few publications have been able to demonstrate: a significant association of these alleles with ADHD ([@b8]; [@b12]).
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